Newsroom

OECD Berlin Workshop to Discuss Costs and Benefits of Protection of Gene-Based Inventions, 24-25 January 2002

 


15/01/2002 - Gene-based inventions offer tremendous promise in improving human health and contributing to economic growth. But to deliver on this promise, a fair and effective system of intellectual property protection will remain fundamental. OECD countries want to ensure that the patenting and licensing of genetic inventions contributes positively to new life saving innovation and does not instead discourage researchers from entering fields where genes have already been patented, or where multiple groups are competing to patent the same gene.

AnOECD Workshop on Genetic Inventions, Intellectual Property Rights, and Licensing Practices will examine the benefits and costs of public and private sector strategies for patenting and licensing genetic inventions at the Federal Ministry of Education and Research, Hannoversche Strasse 28-30, 10115 Berlin on 24-25 January 2002.

Amid ongoing debate about the impact of patenting and licensing on access to new gene-based inventions, a number of interest groups from researchers to doctors and patient groups have signalled concern and sought to cast light on the operation of the current IP system. OECD countries hope to make substantial progress in Berlin to clarify how current licensing practices affect access and thus furnish the debate with much needed substance and solid analysis. The Workshop will bring together experts from business, academia, public and private sector research, government, health care and civil society to examine data on the licensing of genetic inventions, discuss the advantages and disadvantages of certain licensing practices and assess novel strategies (cross-licensing, consortia) that are being developed in response to the proliferation of gene patents.

The findings of the Workshop should increase understanding of the impacts of genetic inventions and help governments, firms and funding agencies to determine how gene-based inventions might best contribute to the public interest.

For further information, journalists are invited to contact Bénédicte Callan, OECD Science, Technology and Industry Directorate (tel. [33] 1 45 24 14 67) or Meggan Dissly, OECD Media Relations Division (tel. [33] 1 45 24 80 94) or Ramona Hering, OECD Berlin Centre (tel. [49] 30 288 8 3542).

 

Related Documents

 

OECD experts view licensing as key in ensuring genetic inventions benefit public health - Conclusions of the Workshop

 

Also Available

Countries list

  • Afghanistan
  • Albania
  • Algeria
  • Andorra
  • Angola
  • Anguilla
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Aruba
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Belarus
  • Belgium
  • Belize
  • Benin
  • Bermuda
  • Bhutan
  • Bolivia
  • Bosnia and Herzegovina
  • Botswana
  • Brazil
  • Brunei Darussalam
  • Bulgaria
  • Burkina Faso
  • Burundi
  • Cambodia
  • Cameroon
  • Canada
  • Cape Verde
  • Cayman Islands
  • Central African Republic
  • Chad
  • Chile
  • China (People’s Republic of)
  • Chinese Taipei
  • Colombia
  • Comoros
  • Congo
  • Cook Islands
  • Costa Rica
  • Croatia
  • Cuba
  • Cyprus
  • Czech Republic
  • Côte d'Ivoire
  • Democratic People's Republic of Korea
  • Democratic Republic of the Congo
  • Denmark
  • Djibouti
  • Dominica
  • Dominican Republic
  • Ecuador
  • Egypt
  • El Salvador
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Ethiopia
  • European Union
  • Faeroe Islands
  • Fiji
  • Finland
  • Former Yugoslav Republic of Macedonia (FYROM)
  • France
  • French Guiana
  • Gabon
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Gibraltar
  • Greece
  • Greenland
  • Grenada
  • Guatemala
  • Guernsey
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Honduras
  • Hong Kong, China
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Iraq
  • Ireland
  • Islamic Republic of Iran
  • Isle of Man
  • Israel
  • Italy
  • Jamaica
  • Japan
  • Jersey
  • Jordan
  • Kazakhstan
  • Kenya
  • Kiribati
  • Korea
  • Kuwait
  • Kyrgyzstan
  • Lao People's Democratic Republic
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Libya
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macao (China)
  • Madagascar
  • Malawi
  • Malaysia
  • Maldives
  • Mali
  • Malta
  • Marshall Islands
  • Mauritania
  • Mauritius
  • Mayotte
  • Mexico
  • Micronesia (Federated States of)
  • Moldova
  • Monaco
  • Mongolia
  • Montenegro
  • Montserrat
  • Morocco
  • Mozambique
  • Myanmar
  • Namibia
  • Nauru
  • Nepal
  • Netherlands
  • Netherlands Antilles
  • New Zealand
  • Nicaragua
  • Niger
  • Nigeria
  • Niue
  • Norway
  • Oman
  • Pakistan
  • Palau
  • Palestinian Administered Areas
  • Panama
  • Papua New Guinea
  • Paraguay
  • Peru
  • Philippines
  • Poland
  • Portugal
  • Puerto Rico
  • Qatar
  • Romania
  • Russian Federation
  • Rwanda
  • Saint Helena
  • Saint Kitts and Nevis
  • Saint Lucia
  • Saint Vincent and the Grenadines
  • Samoa
  • San Marino
  • Sao Tome and Principe
  • Saudi Arabia
  • Senegal
  • Serbia
  • Serbia and Montenegro (pre-June 2006)
  • Seychelles
  • Sierra Leone
  • Singapore
  • Slovak Republic
  • Slovenia
  • Solomon Islands
  • Somalia
  • South Africa
  • South Sudan
  • Spain
  • Sri Lanka
  • Sudan
  • Suriname
  • Swaziland
  • Sweden
  • Switzerland
  • Syrian Arab Republic
  • Tajikistan
  • Tanzania
  • Thailand
  • Timor-Leste
  • Togo
  • Tokelau
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • Turkey
  • Turkmenistan
  • Turks and Caicos Islands
  • Tuvalu
  • Uganda
  • Ukraine
  • United Arab Emirates
  • United Kingdom
  • United States
  • United States Virgin Islands
  • Uruguay
  • Uzbekistan
  • Vanuatu
  • Venezuela
  • Vietnam
  • Virgin Islands (UK)
  • Wallis and Futuna Islands
  • Western Sahara
  • Yemen
  • Zambia
  • Zimbabwe
  • Topics list